Sensi Seeds

DECEMBER 10, 2018

They evaluate data, which is now available thanks to the efforts of the cannabis policy reform movement, and try to provide answers, especially to those who need them most, namely, medical patients. ” An Encouraging Increase. As the article discussed reveals, research on the effects of cannabis on our health is much needed.

Medicine 81

Medicine Research and Development Data Policy 81

CannaTech

SEPTEMBER 23, 2019

The group’s misguided conclusions are a strawman: prohibition of cannabis and the requirements of Helsinki have severely limited research into the plant’s potential medical applications, ergo less gold-standard randomized controlled clinical trial data. We have seen first-hand how cannabis saves lives and improves quality of life.

Patients 79

Patients Policy Clinical Trials Research and Development 79

Cannabis Law Report

JUNE 5, 2019

The Pharmaceutical Organization, Department of Medical Affairs, signed a joint research on standard quality medical marijuana extracts for patients with chemo-allergic cancer, epilepsy, muscle contraction in patients with deteriorating nerve sheaths. Today (30 May) at 09.30 The organization will focus on the use of special treatment schemes.

Pharmaceutical 40

Pharmaceutical Extraction Epilepsy Research and Development 40

Cannabis Law Report

DECEMBER 11, 2021

The clinic established the UK Medical Cannabis Registry to offer patients medical cannabis products at a reduced price while collecting and analysing clinical data from real-world evidence “to expand our understanding of medical cannabis in the UK”. The Sapphire Access Scheme will be open to an additional 2,000 patients in the UK.

Access 52

Access Patients Chronic Pain Treatment 52

Cannabis Law Report

DECEMBER 7, 2021

This trend is also observed in the pediatric population, where MCs are authorized in children for refractory epilepsy, especially in Dravet syndrome and Lennox-Gastaut syndrome 2. A systematic review published in 2017 aimed to identify available data about the therapeutic effect of cannabinoids treatment in children and adolescents.

Safety 52

Safety Cannabinoids Data Events 52

The Joint Blog

FEBRUARY 24, 2021

Cannabis and CBD oils have often been used to reduce the effects of epilepsy and several other neurological issues, so why not Parkinson’s? It discusses a study approved by The Colorado Multiple Institutional Review Board used to collect anonymous data from a wide range of patients.

Treatment 55

Treatment Clinical Trials Collective Patients 55

The Joint Blog

MARCH 16, 2020

For the study researchers examined the use of marijuana over a 12-month period in a cohort of patients with chronic diseases, such as HIV, epilepsy, and fibromyalgia. We recruited patients with various chronic diseases who use cannabis and collected data regarding patterns of cannabis use as well as mental health, personality and QoL.

Patients 49

Patients Marijuana Epilepsy Treatment 49

WeedAdvisor

AUGUST 26, 2019

While the law currently only allows for CBD products to be imported by licensed patients with severe epilepsy, this could soon change. Eligible recipients can import a fixed amount of cannabis every year, at which point the prescription would require renewal. The THC Controversy. .

Strains 45

Strains Cultivation THC Epilepsy 45

Veriheal

JULY 5, 2021

In spite of their fairly equal dominance in the legal cannabis space—collectively, these cannabinoids racked up $17.5 The self-reported data was logged between June 6, 2016, and July 8, 2019. billion in legal U.S.

THC 52

THC CBD Treatment Cannabinoids 52

Cannabis Law Report

MAY 6, 2022

Examples of sellers’ language the FDA views as illegal are the following: “Our line of …CBD oil … is great for insomnia, epilepsy, MS, schizophrenia, and chronic pain.”. Pre-clinical data support the possible use of CBD with Panic Disorder…Bipolar Disorder.”. High level CBD can help manage symptoms of psychosis.”.

THC 52

THC CBD Media Food 52

Weedistry

MARCH 8, 2019

In 2018, medical cannabis became legal in the UK after a nationwide outpouring of support for two young boys who rely on cannabis oil to treat their severe and rare forms of epilepsy, but lingering concerns around the safety and efficiency of the medicine mean that access is still heavily restricted. THC – between 2015 and 2017.

Oil 40

Oil Treatment Patients THC 40

Cannabis Law Report

NOVEMBER 24, 2021

At the same time, the outlook on cannabis research data is largely positive. Chronic pain or pain were the conditions most frequently mentioned in articles about cannabis, followed by epilepsy, cancer or cancer pain, and nausea and chemotherapy. Refractory paediatric epilepsy. Data collection. Cancer pain.

Research and Development 52

Research and Development Medicine Access Media 52

Veriheal

AUGUST 31, 2020

Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death. Essay: “Crowdsourcing User Experience Data for a Targeted Medical Cannabis Journey with Cannamunity” . School: Tufts University.

Research and Development 119

Research and Development Education Agriculture Patients 119

Veriheal

FEBRUARY 21, 2023

” Restricting qualifying conditions also results in limited data collection, hindering the collective understanding of medical cannabis. Furthermore, Nugg MD’s data shows just how vital MMJ access has become in modern society’s health landscape. Many patients take MMJ for more reasons than one.

Access 98

Access Patients Chronic Pain Conditions 98

SpeedWeed

SEPTEMBER 15, 2021

The Mint’s goal for the campaign is to collect 4,200 bras to support the nonprofit. A study from the IQVIA Institute for Human Data Science found that the number of mammograms declined 87 percent compared to the same period a year earlier. . Courtesy of The Mint. Vital Screenings Delayed by Pandemic.

Dispensary 84

Dispensary Collective Events Epilepsy 84

Cannabis Law Report

NOVEMBER 26, 2019

Many unanswered questions and data gaps about CBD toxicity exist, and some of the available data raise serious concerns about potential harm from CBD. Pink Collections Inc. , The FDA has not approved any CBD products other than one prescription human drug product to treat rare, severe forms of epilepsy.

Safety 49

Safety Food CBD Oil 49

SMPL

MAY 26, 2020

And though a few outliers responded well to CBD alone, GW’s data showed that for relieving pain and inflammation, helping with sleep and alleviating seizures and spasms, most patients got the most benefit from an equal mix of CBD and THC — a drug the company called Sativex.

CBD 40

CBD Research and Development Pharmaceutical Seed-To-Sale 40

Cannabis Law Report

OCTOBER 26, 2019

The TGA does not evaluate any data relating to the trial. Data exclusivityThe TG Act provides a data exclusivity period of five years in relation to therapeutic goods containing a new active component (that is, an active substance that has not previously been a component of a product entered in the ARTG).

Clinical Trials 45

Clinical Trials Medicine Research and Development Compliance 45

SMPL

AUGUST 14, 2019

Because CBD exists as an FDA-approved epilepsy drug, Epidiolex, creating a regulatory framework is more complicated. That’s why, he said, FDA is “focusing on a different CBD: Collect Better Data.”. “We If there are data or studies that are relevant to the safety of particular uses of CBD, we want to see them.

CBD 40

CBD Research and Development Hemp Food 40

Cannabis Law Report

NOVEMBER 22, 2019

The Alcohol and Marijuana Control Office has asked retailers to pull products grown by Houston cultivator Calm N Collective from shelves, and put them in quarantine pending further information. Calm N Collective co-owner Ronald Bass claims that the tip is baseless and originated from a disgruntled former employee.

Vaping 45

Vaping Research and Development Seed-To-Sale Hemp 45